About Crimson Integrated
Research
Crimson Integrated Research (CIR) is a globally trusted Integrated Clinical Research Organization dedicated to accelerating drug development and improving patient outcomes through innovative, end-to-end clinical trial solutions. With a team of seasoned professionals across clinical development, biostatistics, regulatory affairs, clinical operations, and pharmacovigilance, we provide comprehensive support from Phase I through IV trials, real-world evidence (RWE) studies, and post-marketing surveillance. Our expertise spans therapeutic areas such as primary care, obesity, oncology, rare diseases, neurology, and cardiovascular health, supported by cutting-edge technology like AI-driven analytics, EDC systems, and decentralized trial (DCT) platforms. Committed to compliance and efficiency, we adhere to ICH-GCP, FDA, EMA, and global regulatory standards, ensuring seamless trial execution. Partner with us to transform scientific discovery into tangible healthcare advancement faster, smarter, and with unwavering quality.
Our Vision
Crimson Integrated Research, CIR. aims to bridge gaps in clinical research by creating an Integrated Research Organization (IRO) that connects healthcare, patients, and biopharma to accelerate innovation and access to life-changing therapies.
Our Team
Emad S. Shaikh
MD, MPH
Dr Majid Atique
MD, DABOM
Rashid Atique
MD
Join a remarkable team doing remarkable work
Crimson Integrated Research careers offer competitive pay and benefits, and reward high performance with excellent opportunities.
Whether you’re an industry veteran or are looking to take your first step into clinical research, we invite you to apply at Crimson.
